{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:19:17Z","timestamp":1766067557118,"version":"3.37.3"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA221747"],"award-info":[{"award-number":["P50CA221747"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.1093\/neuonc\/noac142","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T12:21:46Z","timestamp":1656159706000},"page":"1687-1688","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5923-0677","authenticated-orcid":false,"given":"Priya","family":"Kumthekar","sequence":"first","affiliation":[{"name":"Department of Neurology at The Feinberg School of Medicine at Northwestern University and The Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago, Illinois , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-2319","authenticated-orcid":false,"given":"Seema","family":"Nagpal","sequence":"additional","affiliation":[{"name":"Department of Neurology at Stanford University, Department of Neurology, Division of Neuro-oncology , Stanford, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"2022100306592970800_CIT0001","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","article-title":"Heterotransplantation of a human malignant tumour to \u201cNude\u201d mice","volume":"77","author":"Rygard","year":"1969","journal-title":"Acta Pathol Microbiol Scand."},{"issue":"5","key":"2022100306592970800_CIT0002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","article-title":"Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases","author":"Vaubel","year":"2020;","journal-title":"Clin Cancer Res."},{"issue":"20","key":"2022100306592970800_CIT0003","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/0008-5472.CAN-20-0291","article-title":"Brain metastasis cell lines panel: a public resource of organotropic cell lines","volume":"80","author":"Valiente","year":"2020","journal-title":"Cancer Res."},{"issue":"6","key":"2022100306592970800_CIT0004","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapt the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell."},{"journal-title":"Neuro Oncol","article-title":"A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma","author":"Law","key":"2022100306592970800_CIT0005"},{"key":"2022100306592970800_CIT0006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nec.2010.08.006","article-title":"Leptomeningeal disease","volume":"22","author":"Groves","year":"2011","journal-title":"Neurosurg Clin N Am."},{"issue":"42","key":"2022100306592970800_CIT0007","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"2022100306592970800_CIT0008","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1158\/1078-0432.CCR-19-2840","article-title":"Proteomic analysis of CSF from patients with leptomeningeal melanoma metastases identifies signatures associated with disease progression and therapeutic resistance","volume":"26","author":"Smalley","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noac142\/44319047\/noac142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/10\/1687\/46229418\/noac142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/10\/1687\/46229418\/noac142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T07:00:07Z","timestamp":1664780407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/24\/10\/1687\/6617860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":8,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,6,25]]},"published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noac142","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"type":"print","value":"1522-8517"},{"type":"electronic","value":"1523-5866"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,6,25]]}}}